跳至主要内容
临床试验/NCT01183832
NCT01183832已完成不适用

Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects

Centre Oscar Lambret28 个研究点 分布在 2 个国家目标入组 490 人开始时间: 2005年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
490
试验地点
28
主要终点
radiation side effects

研究概览

简要总结

This study is a description of the radiation effects on the healthy tissues in patients receiving Anastrozole, sequential or in association with radiotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Post-menopausal woman without superior age limit
  • No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone receptor positive, treated by conservative surgery or total mastectomy and requiring additive treatment by radiotherapy and hormonotherapy
  • The patients including in another clinical trial can be include in this observatory

排除标准

  • 未提供

结局指标

主要结局

radiation side effects

时间窗: 5 years after the end of radiotherapy

Describe, in real situation, the ionisant radiation effects on the healthy tissues in patients receiving anastrazole in association or sequential with radiotherapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验